These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7699677)
21. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions. Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692 [TBL] [Abstract][Full Text] [Related]
22. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months. Kremer JM; Petrillo GF; Hamilton RA J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679 [TBL] [Abstract][Full Text] [Related]
23. Creatinine clearance but not serum creatinine alone predicts long-term postoperative survival after lower extremity revascularization. Maithel SK; Pomposelli FB; Williams M; Sheahan MG; Scovell SD; Campbell DR; LoGerfo FW; Hamdan AD Am J Nephrol; 2006; 26(6):612-20. PubMed ID: 17183190 [TBL] [Abstract][Full Text] [Related]
24. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy. Fries JF; Williams CA; Singh G; Ramey DR J Rheumatol; 1997 May; 24(5):838-44. PubMed ID: 9150069 [TBL] [Abstract][Full Text] [Related]
25. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy. Kremer JM; Petrillo GF; Hamilton RA J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678 [TBL] [Abstract][Full Text] [Related]
27. Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis. Pugh MC; Pugh CB Clin Pharm; 1987 Jun; 6(6):475-91. PubMed ID: 3319362 [TBL] [Abstract][Full Text] [Related]
35. Serum creatinine is a poor marker of GFR in nephrotic syndrome. Branten AJ; Vervoort G; Wetzels JF Nephrol Dial Transplant; 2005 Apr; 20(4):707-11. PubMed ID: 15713698 [TBL] [Abstract][Full Text] [Related]
36. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Svenson KL; Lithell H; Hällgren R; Vessby B Arch Intern Med; 1987 Nov; 147(11):1917-20. PubMed ID: 3675092 [TBL] [Abstract][Full Text] [Related]
37. [Ocular changes caused by long-lasting use of chloroquine and its derivatives in rheumatoid disease]. Drewnowska-Sochańska A; Kuprianowicz W; Petrus B Klin Oczna; 1970; 40(4):499-503. PubMed ID: 5453064 [No Abstract] [Full Text] [Related]
38. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole. Husain Z; Runge LA J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692 [TBL] [Abstract][Full Text] [Related]
39. Effect of drug-induced hyperuricaemia on renal function in Nigerians with pulmonary tuberculosis. Adebisi SA; Oluboyo PO; Okesina AB Afr J Med Med Sci; 2000; 29(3-4):297-300. PubMed ID: 11714010 [TBL] [Abstract][Full Text] [Related]
40. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs. Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]